Tower Research Capital (TRC)’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$17.8K Buy
24,879
+11,172
+82% +$7.98K ﹤0.01% 3744
2025
Q1
$8.92K Buy
13,707
+5,996
+78% +$3.9K ﹤0.01% 3841
2024
Q4
$14.2K Buy
7,711
+4,034
+110% +$7.42K ﹤0.01% 3472
2024
Q3
$12.7K Sell
3,677
-8,204
-69% -$28.4K ﹤0.01% 3565
2024
Q2
$34.8K Buy
11,881
+7,257
+157% +$21.3K ﹤0.01% 3373
2024
Q1
$26.1K Sell
4,624
-4,772
-51% -$27K ﹤0.01% 2767
2023
Q4
$40.3K Sell
9,396
-5,732
-38% -$24.6K ﹤0.01% 3272
2023
Q3
$52.5K Buy
15,128
+11,708
+342% +$40.6K ﹤0.01% 2509
2023
Q2
$15.9K Buy
3,420
+255
+8% +$1.19K ﹤0.01% 3577
2023
Q1
$15K Buy
3,165
+1,822
+136% +$8.64K ﹤0.01% 3815
2022
Q4
$11K Sell
1,343
-1,907
-59% -$15.6K ﹤0.01% 3869
2022
Q3
$18K Sell
3,250
-2,454
-43% -$13.6K ﹤0.01% 4024
2022
Q2
$30K Buy
5,704
+4,471
+363% +$23.5K ﹤0.01% 3386
2022
Q1
$10K Sell
1,233
-4,210
-77% -$34.1K ﹤0.01% 4348
2021
Q4
$81K Buy
5,443
+2,428
+81% +$36.1K ﹤0.01% 2377
2021
Q3
$57K Sell
3,015
-420
-12% -$7.94K ﹤0.01% 2847
2021
Q2
$64K Sell
3,435
-126
-4% -$2.35K ﹤0.01% 2813
2021
Q1
$81K Buy
3,561
+1,474
+71% +$33.5K ﹤0.01% 2752
2020
Q4
$45K Sell
2,087
-16,328
-89% -$352K ﹤0.01% 3219
2020
Q3
$185K Buy
18,415
+11,533
+168% +$116K ﹤0.01% 2649
2020
Q2
$53K Buy
+6,882
New +$53K ﹤0.01% 3001
2019
Q4
Sell
-110
Closed -$1K 4318
2019
Q3
$1K Sell
110
-1,092
-91% -$9.93K ﹤0.01% 3922
2019
Q2
$14K Buy
1,202
+968
+414% +$11.3K ﹤0.01% 2380
2019
Q1
$3K Sell
234
-5,284
-96% -$67.7K ﹤0.01% 3321
2018
Q4
$49K Buy
+5,518
New +$49K ﹤0.01% 1299